KMT2A and acute myeloid leukemia: PAFc mediated recruitment of the H3K9 methyltransferases, such as SETDB1 antagonizes Mixed-Lineage Leukemia (MLL) signaling, and inhibition of SETB1 promotes AML cell proliferation5,6.